Endymed Cash And Equivalents vs. Current Valuation
| ENDY Stock | 302.00 11.90 4.10% |
For Endymed profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Endymed to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Endymed utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Endymed's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Endymed over time as well as its relative position and ranking within its peers.
Endymed |
Endymed Current Valuation vs. Cash And Equivalents Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Endymed's current stock value. Our valuation model uses many indicators to compare Endymed value to that of its competitors to determine the firm's financial worth. Endymed is one of the top stocks in cash and equivalents category among its peers. It is rated below average in current valuation category among its peers reporting about 0.37 of Current Valuation per Cash And Equivalents. The ratio of Cash And Equivalents to Current Valuation for Endymed is roughly 2.72 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Endymed by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Endymed's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Endymed Current Valuation vs. Cash And Equivalents
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Endymed |
| = | 5.02 M |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Endymed |
| = | 1.85 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Endymed Current Valuation vs Competition
Endymed is rated below average in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about (6.06 Billion). Endymed adds roughly 1.85 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Endymed Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Endymed, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Endymed will eventually generate negative long term returns. The profitability progress is the general direction of Endymed's change in net profit over the period of time. It can combine multiple indicators of Endymed, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Endymed Ltd, a medical technology company, designs, develops, and commercializes energy based medical aesthetic treatment systems for the professional and consumer markets worldwide. Endymed Ltd was founded in 2007 and is based in New York, New York. ENDYMED LTD operates under Medical Devices classification in Israel and is traded on Tel Aviv Stock Exchange.
Endymed Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Endymed. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Endymed position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Endymed's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Endymed without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Price Ceiling Movement Now
Price Ceiling MovementCalculate and plot Price Ceiling Movement for different equity instruments |
| All Next | Launch Module |
Use Investing Themes to Complement your Endymed position
In addition to having Endymed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Music and Video Thematic Idea Now
Music and Video
Companies specializing in music, video and movie production and distribution. The Music and Video theme has 36 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Music and Video Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Endymed Stock
To fully project Endymed's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Endymed at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Endymed's income statement, its balance sheet, and the statement of cash flows.